OBJECTIVES/HYPOTHESIS: To assess the risk of level V nodal involvement for early T-stage and node positive oropharyngeal squamous cell carcinoma (ORO-SCC). METHODS: Retrospective analysis performed on patients with ORO-SCC and clinically positive lymph nodes who had undergone upfront elective dissection of level V before definitive chemoradiotherapy. Pathological data collected and prevalence of involvement of level V determined. RESULTS: A total of 119 patients had level V dissection. The prevalence of pathologically positive lymph nodes in level V was 3.4% (4/119). Moreover, it was observed only in the presence of pathological involvement of multiple other nodal levels (4/52 patients, 7.7% vs. 0/67 in patients with a single nodal station involved, chi(2)P = .02). CONCLUSIONS: Subclinical involvement of level V in ORO-SCC is rare, especially in the presence of disease confined to a single nodal level. The present data do not support its dissection after primary chemoradiotherapy.
No takes yet. Share an insight, caveat, or question.
Pattani et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: